BSX Stock Forecast 2025-2026
Distance to BSX Price Targets
BSX Price Momentum
10 Quality Stocks Worth Considering Now
Researching Boston Scientific (BSX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on BSX and similar high-potential opportunities.
Latest BSX Stock Price Targets & Analyst Predictions
Based on our analysis of 31 Wall Street analysts, BSX has a bullish consensus with a median price target of $116.00 (ranging from $84.00 to $135.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $95.12, the median forecast implies a 22.0% upside. This outlook is supported by 29 Buy, 4 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Marie Thibault at BTIG, suggesting a 11.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BSX Analyst Ratings
BSX Price Target Range
Latest BSX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BSX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 16, 2025 | Needham | Mike Matson | Buy | Upgrade | $113.00 |
| Apr 11, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $113.00 |
| Mar 3, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Feb 10, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $118.00 |
| Feb 10, 2025 | Stifel | Rick Wise | Buy | Maintains | $120.00 |
| Feb 7, 2025 | UBS | Danielle Antalffy | Buy | Maintains | $130.00 |
| Feb 6, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $122.00 |
| Feb 6, 2025 | Stifel | Rick Wise | Buy | Maintains | $115.00 |
| Feb 6, 2025 | RBC Capital | Shagun Singh | Outperform | Maintains | $116.00 |
| Feb 6, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $118.00 |
| Feb 6, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Feb 6, 2025 | Morgan Stanley | Patrick Wood | Overweight | Maintains | $120.00 |
| Feb 6, 2025 | Raymond James | Jayson Bedford | Strong Buy | Maintains | $122.00 |
| Feb 3, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $115.00 |
| Jan 31, 2025 | Raymond James | Jayson Bedford | Strong Buy | Maintains | $119.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $110.00 |
| Dec 16, 2024 | JP Morgan | Robbie Marcus | Overweight | Maintains | $110.00 |
| Dec 12, 2024 | TD Cowen | Joshua Jennings | Buy | Maintains | $110.00 |
| Dec 11, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $100.00 |
| Dec 11, 2024 | Citigroup | Joanne Wuensch | Buy | Maintains | $107.00 |
Boston Scientific Corporation (BSX) Competitors
The following stocks are similar to Boston Scientific based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Boston Scientific Corporation (BSX) Financial Data
Boston Scientific Corporation has a market capitalization of $140.69B with a P/E ratio of 76.1x. The company generates $16.75B in trailing twelve-month revenue with a 11.1% profit margin.
Revenue growth is +22.4% quarter-over-quarter, while maintaining an operating margin of +17.3% and return on equity of +8.9%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Boston Scientific Corporation (BSX) Business Model
About Boston Scientific Corporation
Develops innovative medical devices for healthcare.
Boston Scientific designs, manufactures, and markets medical devices used in various interventional specialties, generating revenue by supplying these products to healthcare providers globally. Their focus on minimally invasive solutions enhances patient care while reducing the need for major surgical interventions.
Founded in 1979 and based in Marlborough, Massachusetts, Boston Scientific is a key player in the healthcare sector, driving advancements in medical technology through continuous research and development. The company's innovative approach not only improves patient outcomes but also positions it as a significant contributor to the future of healthcare delivery.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
53,000
CEO
Mr. Michael F. Mahoney
Country
United States
IPO Year
1992
Website
www.bostonscientific.comBoston Scientific Corporation (BSX) Latest News & Analysis
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
2 days agoBoston Scientific's Q1 2025 performance will be assessed beyond top and bottom-line estimates, focusing on key metric projections for a deeper understanding of its business outcomes.
Projections for key metrics provide deeper insights into Boston Scientific's operational performance, influencing stock valuation and investor sentiment ahead of earnings reports.
Boston Scientific stock is forming a first-stage base, indicating a potential early entry point as the company approaches its first-quarter earnings report.
Boston Scientific's stock formation suggests potential upward momentum, signaling a favorable entry point ahead of earnings, which could impact investor sentiment and stock performance.
BSX is projected to report strong international growth in Q1, driven by above-market performance across all its business units.
Strong international momentum and above-market growth in all business units indicate BSX's potential for increased revenue and profitability, signaling positive trends for investors.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
2 days agoBoston Scientific (BSX) closed at $95.12 in the latest trading session, reflecting a decrease of 0.14% from the previous day.
A slight decrease in Boston Scientific's stock price may indicate market volatility or investor sentiment shifts, affecting trading strategies and potential returns.
Investors are comparing Phibro Animal Health (PAHC) and Boston Scientific (BSX) in the Medical - Products sector for potential undervalued stock opportunities.
The comparison of Phibro Animal Health and Boston Scientific highlights potential undervalued investment opportunities in the Medical - Products sector, influencing stock selection strategies.
Boston Scientific (BSX) closed at $93.67, up 1.11% in the latest trading session.
Boston Scientific's positive price movement signals investor confidence and potential growth, impacting overall market sentiment and influencing trading strategies.
Frequently Asked Questions About BSX Stock
What is Boston Scientific Corporation's (BSX) stock forecast for 2025?
Based on our analysis of 31 Wall Street analysts, Boston Scientific Corporation (BSX) has a median price target of $116.00. The highest price target is $135.00 and the lowest is $84.00.
Is BSX stock a good investment in 2025?
According to current analyst ratings, BSX has 29 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $95.12. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BSX stock?
Wall Street analysts predict BSX stock could reach $116.00 in the next 12 months. This represents a 22.0% increase from the current price of $95.12. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Boston Scientific Corporation's business model?
Boston Scientific designs, manufactures, and markets medical devices used in various interventional specialties, generating revenue by supplying these products to healthcare providers globally. Their focus on minimally invasive solutions enhances patient care while reducing the need for major surgical interventions.
What is the highest forecasted price for BSX Boston Scientific Corporation?
The highest price target for BSX is $135.00 from at , which represents a 41.9% increase from the current price of $95.12.
What is the lowest forecasted price for BSX Boston Scientific Corporation?
The lowest price target for BSX is $84.00 from Marie Thibault at BTIG, which represents a -11.7% decrease from the current price of $95.12.
What is the overall BSX consensus from analysts for Boston Scientific Corporation?
The overall analyst consensus for BSX is bullish. Out of 31 Wall Street analysts, 29 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $116.00.
How accurate are BSX stock price projections?
Stock price projections, including those for Boston Scientific Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.